Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5 -- Ignore unavailable to you. Want to Upgrade?

To: GARY P GROBBEL who wrote (37976)	8/3/2005 9:51:53 AM
From: GARY P GROBBEL	Read Replies (4) \| Respond to of 120405

IAUS...this is what has been moving the stock- Solar Power Breakthrough Wednesday July 27, 8:00 am ET New Low-Cost Solar Energy May Replace Gas SALEM, Utah--(BUSINESS WIRE)--July 27, 2005--Will solar energy ever overtake the oil market? The solar revolution may be closer than you think. Breakthrough solar power technology developed by International Automated Systems Inc. (OTCBB: IAUS - News) may become the first solar to compete with gas. Low-cost energy produced by IAUS' new patented and patent-pending solar technology can be used to generate electricity or produce clean fuels such as hydrogen and green methanol (gasoline replacements) at a competitive price. IAUS' unique thin-film solar panels can be produced at a fraction of the cost of today's photovoltaic solar panels. IAUS is on schedule to begin mass production of its solar panels by September 2005. Once in production, IAUS will be able to turn out nearly 200 megawatts of solar panels yearly, nearly 10 times greater capacity than a $100 million photovoltaic fabrication plant. A solar area of only 100 square miles -- a size of land that equals only nine percent of the state of Nevada -- can generate enough electricity for the entire United States. "The discovery of economical solar energy is more valuable than oil," said Neldon Johnson, president and CEO of International Automated Systems Inc. "The sun's energy is free, clean and virtually unlimited. IAS' new solar technology is a discovery of historical proportions that we hope will revolutionize energy production throughout the world." The world energy market is $3 trillion per year. This $3 trillion does not represent nearly 30% of the world without electricity. About International Automated Systems Inc. (www.iaus.com) Founded in 1988, International Automated Systems Inc. develops high-technology products for diverse markets such as energy production, wireless communications, consumer purchasing and financial transactions. The company, founded by a former AT&T communications engineer, is based in Salem, Utah.

To: GARY P GROBBEL who wrote (37976)	8/3/2005 10:17:28 AM
From: GemSeeker	Read Replies (1) \| Respond to of 120405

ILE...2.78 this was recently in the 7 and 8 range but a huge selloff this week brought it down into micro territory. Very compelling stock at this price. Some details for those who might be interested: Everyone knows about botox and its extreme popularity amongst the pampered classes. A huge industry ($900 million this year is current projection) just getting started. Well, botox has certain disadvantages. The biggest one being that it's effects are temporary. The substance is eventually absorbed into the body. Since it is a foreign substance it is also subject to rejection. A Houston outfit by the name of Isolagen (ILE) has developed a new approach to wrinkle removal. They take a smale piece of skin the from behind the ear and grow the cells in the lab for about 8 weeks, and then inject them beneath frown lines and scars by a plastic surgeon. Isolagen claims that the implanted cells grow in the same way as ordinary skin cells and that, unlike collagen fillers or the nerve-paralysing toxin Botox, the effect does not wear off. In fact, it claims, the effects get better over time. If so, it may be the closest anyone has come to achieving true skin regeneration. Since it comes from the recipients body originally, it is never rejected. Britain and Australia place Isolagen in the same category as tissue banks. This means that while the company's labs have to comply with certain standards, it did not have to submit safety and efficacy data before marketing its treatment. Isolagen is also opening facilities in New Zealand, South Korea and Hong Kong. The Isolagen treatment was briefly available in the US in the mid-1990s, but the Food and Drug Administration asked the company to withdraw it voluntarily while it decided how to regulate therapies of this kind. It later asked Isolagen to perform clinical trials, though with fewer patients than in most phase II and III trials. Approval will come via a BLA which is an expidited FDA fast track process. News that came out this week suggests the company made a real bonehead mistake in teaching the docs in the trials about the proper injection techniques. Has cost them huge market cap and added at least 9 months to the entire approval process. Hence the 50% haircut in the lsat couple days. Absolutely nothing in the data available so far would indicate any problems with efficacy and ultimate FDA approval. ILE has also done some preliminary studies in the treatment of periodontal disease with very promising results. ILE process has 5 patents with more coming. 30 mil shares o/s with 27 in float and a market cap of $83M. Cost of this process is fairly high. A high priority at ILE these days is to get the cost down. They recently indicated some significant progress in this regard. The boomers have proved their willingness to spend big bucks on wrinkle remedies. Even if the treatment remains expensive, the market is vast. The surprising thing about ILE is that no one knows it exists. No RB board, AOL board, SI board and a very quiet yahoo board (until recently!). Flying totally under everybody's radar, which is a good place to find 'em. Once FDA appproval comes through, I would expect visibility to pick up dramatically. Along with price. No guaranty, but the real possibility exists of getting in on the "next big thing" in plastic surgery way before the rest of the crowd.